Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04887857
Title A Study to Assess Safety and Tolerability of CC-486 (ONUREG, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML) (OMNIVERSE)
Acronym OMNIVERSE
Recruitment Completed
Gender
Phase Phase I
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Local Institution - 104 Stanford California 94305-5317 United States Details
Local Institution - 110 Denver Colorado 80218 United States Details
Local Institution - 105 Boston Massachusetts 02114 United States Details
Local Institution - 106 New York New York 10029 United States Details
Local Institution - 113 New York New York 10065 United States Details
Local Institution - 102 Cleveland Ohio 44195 United States Details
Local Institution - 111 Oklahoma City Oklahoma 73104 United States Details
Local Institution - 101 Houston Texas 77003 United States Details
Local Institution - 202 North Melbourne Victoria 3002 Australia Details
Local Institution - 201 Melbourne 3004 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field